Stocks and InvestingStocks and Investing
Tue, February 20, 2024
Mon, February 19, 2024
Fri, February 16, 2024

Gregory Renza Maintained (AGIO) at Buy with Decreased Target to $42 on, Feb 16th, 2024


Published on 2024-10-28 09:03:09 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Buy with Decreased Target from $43 to $42 on, Feb 16th, 2024.

Gregory has made no other calls on AGIO in the last 4 months.



There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, all agree with Gregory's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Tessa Romero of "JP Morgan" Maintained at Hold with Increased Target to $31 on, Tuesday, January 23rd, 2024
  • Salveen Richter of "Goldman Sachs" Maintained at Hold with Decreased Target to $28 on, Friday, November 3rd, 2023